Detalhe da pesquisa
1.
Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients.
Hepatology
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38630497
2.
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs.
Value Health
; 26(6): 883-892, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36646278
3.
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.
Clin Infect Dis
; 72(8): 1392-1400, 2021 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32166305
4.
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
N Engl J Med
; 378(4): 354-369, 2018 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29365309
5.
Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
Clin Gastroenterol Hepatol
; 19(3): 573-579.e1, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32526342
6.
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs.
Clin Infect Dis
; 70(9): 1900-1906, 2020 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31233117
7.
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study.
Clin Infect Dis
; 70(11): 2369-2376, 2020 05 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31300820
8.
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease.
Clin Infect Dis
; 69(10): 1657-1664, 2019 10 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30923816
9.
Short-Duration AL-335, Odalasvir, With or Without Simeprevir, in Patients With HCV GT1 or 3 Infection Without Cirrhosis.
Hepatology
; 68(6): 2145-2157, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30070722
10.
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
N Engl J Med
; 373(8): 705-13, 2015 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-26196665
11.
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
N Engl J Med
; 373(27): 2608-17, 2015 Dec 31.
Artigo
Inglês
| MEDLINE | ID: mdl-26575258
12.
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.
Gastroenterology
; 152(6): 1366-1371, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28137593
13.
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
Gastroenterology
; 153(1): 113-122, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28390869
14.
Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen.
Hepatology
; 66(4): 1083-1089, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28498551
15.
Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections.
Gastroenterology
; 151(3): 448-456.e1, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27240903
16.
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.
Gastroenterology
; 151(5): 902-909, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27486033
17.
A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
Br J Clin Pharmacol
; 88(3): 1385-1386, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34423463
18.
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.
N Engl J Med
; 368(1): 34-44, 2013 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-23281974
19.
Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection.
Gastroenterology
; 149(6): 1454-1461.e1, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26261007
20.
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.
Ann Intern Med
; 163(11): 809-17, 2015 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26551263